S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Genmab A/S Earnings Date, Estimates & History

+24.87 (+8.32 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $323.95
50-Day Range
MA: $400.58
52-Week Range
Now: $323.95
Volume415 shs
Average Volume1,338 shs
Market Capitalization$19.98 billion
P/E Ratio4.60
Dividend YieldN/A


Genmab A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Genmab A/S Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Genmab A/S (OTCMKTS GNMSF) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020Q3 2020$1.26$1.26$270.67 millionN/A
8/12/2020Q2 2020$65.11$65.11$805.11 millionN/A
5/6/2020Q1 2020$0.60$0.60$131.69 millionN/A
2/19/2020Q4 2019$3.43$3.43$438.89 millionN/A
11/6/2019Q3 2019$1.23$1.23$154.91 millionN/A
8/14/2019Q2 2019$0.36$0.20$0.20$129.17 million$116.49 millionN/A
5/8/2019Q1 2019$0.18$0.18$89.93 millionN/A
2/20/2019Q4 2018$2.06$2.06$188.97 millionN/A
11/14/2018Q3 2018$0.45$0.45$93.34 millionN/A
8/8/2018Q2 2018$0.68$0.68$81.60 millionN/A
5/8/2018Q1 2018$0.72$0.54$0.54$107.90 million$112.36 millionN/A
2/21/2018Q4 2017$2.00$2.00$161.06 millionN/A
11/8/2017Q3 2017($0.01)($0.01)$51.08 millionN/A
8/9/2017Q2 2017$0.73$0.73$114.26 millionN/A
5/10/2017Q1 2017$0.04$0.04$35.19 million$35.93 millionN/A
3/28/2017Q4 2016$1.98$1.98$134.64 millionN/A
11/2/2016Q3 2016$0.46$0.46$54.70 millionN/A
8/9/2016Q2 2016$0.24$0.41$0.41$49.68 million$53.72 millionN/A
5/10/2016Q1 2016($0.25)($0.03)($0.03)$10.31 million$25.15 millionN/A
2/17/2016Q4 2015$0.95$0.95$84.32 millionN/A
11/3/2015Q3 2015$0.34$0.34$41.41 millionN/A
8/11/2015Q2 2015$0.44$0.04$0.04$47.57 million$25.76 millionN/A
5/12/2015Q1 2015$0.55$0.55$16.19 millionN/A
11/5/2014Q3 2014$0.45$0.47$0.47$53.94 million$45.65 millionN/A
8/13/2014Q2 2014($0.06)($0.08)($0.08)$26.02 million$20.79 millionN/A
5/7/2014Q1 2014($0.09)$0.33$0.33$21.18 million$46.08 millionN/A
11/6/2013Q3 2013($0.01)$0.02$0.02$25.52 million$27.12 millionN/A
8/14/2013Q2 2013($0.01)($0.09)($0.09)$24.45 million$24.54 millionN/A
5/7/2013Q1 2013$0.11($0.03)$28.09 millionN/A
11/7/2012Q3 2012($0.17)($0.17)($0.13)N/A
8/15/2012Q2 2012($0.32)$0.03$0.07N/A
5/15/2012Q1 2012($0.25)($0.23)($0.19)N/A
11/2/2011Q3 2011($0.04)$1.41N/A
5/11/2011Q1 2011($0.16)($0.43)($0.39)N/A
11/22/2010Q3 2010$0.48$1.03N/A
8/17/2010Q2 2010($0.46)($0.30)($0.25)N/A
5/11/2010Q1 2010($0.77)($0.47)($0.40)N/A
11/10/2009Q3 2009($1.17)($0.44)($0.44)N/A
8/18/2009Q2 2009($1.18)($0.54)($0.54)N/A
5/12/2009Q1 2009($1.04)($0.79)($0.79)N/A
8/27/2008Q2 2008($1.38)($1.38)N/A
5/28/2008Q1 2008($0.95)($0.95)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.